In a groundbreaking medical case, doctors in the US and Canada have successfully treated a toddler with a rare genetic disease, metachromatic leukodystrophy (MLD), using a pioneering gene therapy technique before she was born.

This treatment, which could not be accessed in the United States due to regulatory constraints, led the family to seek help internationally, shedding light on the urgent need for policy reform concerning the approval of personalized treatments.